39493-62-4

Basic information

• Product Name: METHYL 4-HYDROXY-6-METHYL-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE
• Synonyms: METHYL 4-HYDROXY-6-METHYL-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE;5,6-Dihydroorsellinicacidmethylester~4-Hydroxy-6-methyl-2-oxo-3-cyclohexene-1-carboxylatemethylester~Methyl5-methy;4-hydroxy-6-methyl-2-oxo-3-cyclohexene-1-carboxylate methyl ester;5,6-dihydroorsellinic acid methyl ester;2,4-diketo-6-methyl-cyclohexane-1-carboxylic acid methyl ester;2-methyl-4,6-dioxo-1-cyclohexanecarboxylic acid methyl ester;methyl 2-methyl-4,6-dioxo-cyclohexane-1-carboxylate;methyl 2-methyl-4,6-dioxocyclohexane-1-carboxylate
• CAS NO: 39493-62-4
• Molecular Formula: C₉H₁₂O₄
• Molecular Weight: 184.19
• EINECS: -0
• Mol File: 39493-62-4.mol
• Article Data: 6

Chemical Properties

• Melting Point: 122-124°C
• Boiling Point: 289.4°Cat760mmHg
• Flash Point: 113°C
• Appearance: /
• Density: 1.237g/cm³
• Vapor Pressure: 0.000243mmHg at 25°C
• Refractive Index: 1.511
• PKA: 5.08±0.58(Predicted)
• BRN: 5258501
• CAS DataBase Reference: METHYL 4-HYDROXY-6-METHYL-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-HYDROXY-6-METHYL-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE(39493-62-4)
• EPA Substance Registry System: METHYL 4-HYDROXY-6-METHYL-2-OXO-3-CYCLOHEXENE-1-CARBOXYLATE(39493-62-4)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 39493-62-4(Hazardous Substances Data)

Usage

General Description

Methyl 4-hydroxy-6-methyl-2-oxo-3-cyclohexene-1-carboxylate is a chemical compound with the molecular formula C10H14O4. It is a derivative of cyclohexene and contains a carbonyl group, a hydroxyl group, and a methyl group. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has potential applications in the development of new drugs and pesticides due to its unique structure and reactivity. Additionally, it can be used in organic synthesis for the preparation of complex molecules. However, as with any chemical compound, proper handling and safety precautions should be followed to prevent exposure and potential hazards.

InChI:InChI=1/C9H12O4/c1-5-3-6(10)4-7(11)8(5)9(12)13-2/h4-5,8,10H,3H2,1-2H3

Upstream product

• 625-33-2 3-penten-2-one 
• 108-59-8 malonic acid dimethyl ester 
• 623-43-8 crotonic acid methyl ester 
• 105-45-3 acetoacetic acid methyl ester 
• 623-43-8 methyl crotonate 

Downstream Products

• 149221-14-7 methyl 4'-<(4'-chloro-2'-pyridinyl)amino>-6-methyl-2-oxocyclohex-3-en-1-oate 
• 58106-55-1 2,4-dihydroxy-3-bromo-6-methyl-benzoic acid methyl ester 
• 520-43-4 2-hydroxy-4-methoxy-6-methyl-benzoic acid methyl ester 
• 715-33-3 methyl 2,4-dihydroxy-3,5-dibromo-6-methylbenzoate 
• 1586771-79-0 C₁₅H₁₅Cl₂NO₃ 
• 1586771-77-8 C₁₅H₁₅Cl₂NO₃ 
• 1586771-85-8 C₁₅H₁₄Cl₃NO₃ 
• 1586771-83-6 C₁₅H₁₄Cl₃NO₃ 
• 1586771-96-1 methyl 4-(2',4'-dibromophenylamino)cyclohex-3-en-6-methyl-2-oxo-1-oate 
• 1147846-91-0 methyl 4-(((S)-3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methylamino)-6-methyl-2-oxocyclohex-3-enecarboxylate 
• 1147846-89-6 methyl 4-(3-fluoro-4-morpholinophenylamino)-6-methyl-2-oxocyclohex-3-ene-1-carboxylate 
• 1147847-02-6 tert-Butyl 4-(2-fluoro-4-(4-(methoxycarbonyl)-5-methyl-3-oxocyclohex-1-enylamino)phenyl)piperazine-1-carboxylate 
• 142458-07-9 6-Methyl-4-(4-methyl-benzylamino)-2-oxo-cyclohex-3-enecarboxylic acid methyl ester 
• 142458-10-4 4-(4-Fluoro-benzylamino)-6-methyl-2-oxo-cyclohex-3-enecarboxylic acid methyl ester 

Relevant articles and documents

Cajan element structure and methods in the application of preparing antibacterial drug

The invention belongs to the field of medicines and discloses a longistyline analogue and an application thereof in preparation of an antibacterial drug. The longistyline analogue has a structure as shown in the formula I described in the specification, w

CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE

Provided are cajanine structure analogous compounds, synthesis method and pharmacological effects thereof, the compounds of the present invention having the structure as represented by general formulas I, II, III, IV and V. Also provided are pharmaceutical compositions containing the compounds as active ingredient, and uses thereof; the compounds of the present invention having the pharmacological activities such as anti-virus, anti-virus-infection, nerve protection, anti-metabolic-diseases and the like. Also provided is a chemical total synthesis preparation method of the natural products cajanine, cajanine A and cajanine C. The present invention lays a foundation for the in-depth study and development of the compounds as clinical drugs in the future.

Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones

Several cyclic enaminone esters were synthesized, characterized, and evaluated for anticonvulsant and antibacterial activities using standardized tests. A series of enaminones were mainly phenyl analogs of anticonvulsant enaminones, while a second series